A carregar...
Synthesis and validation of [(18)F]mBPET-1, a fluorine-18 labelled mTOR inhibitor derivative based on a benzofuran backbone
BACKGROUND: Targeted therapy of HER2 positive breast cancer has led to clinical success in some cases with primary and secondary resistance being major obstacles. Due to the substantial involvement of mTOR kinase in cell growth and proliferation pathways it is now targeted in combination treatments...
Na minha lista:
| Publicado no: | EJNMMI Radiopharm Chem |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6977806/ https://ncbi.nlm.nih.gov/pubmed/31974638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41181-020-0089-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|